Primary Site >> Stomach Cancer
Gene >> SLC2A1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Glucose uptake in the human gastric cancer cell line, MKN28, is increased by insulin stimulation. PMID: 10403543 Ref: Expression of facilitative glucose transporters in gastric tumors. PMID: 10522065 |
Ref: Glucose transporter 1 (GLUT1) expression is associated with intestinal type of gastric carcinoma. PMID: 10983690 |
Ref: Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. PMID: 11505409 |
Ref: [Glut1 expression and its relation with the absorption of 18F-FDG in stomach cancer]. PMID: 15312513 |
Ref: Regulation of human peptide transporter 1 (PEPT1) in gastric cancer cells by anticancer drugs. PMID: 16253763 Ref: Is the hypoxia-inducible factor pathway important in gastric cancer? PMID: 16290133 |
Ref: Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. PMID: 16557436 Ref: Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. PMID: 17143338 Ref: Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. PMID: 17294670 |
Ref: [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis]. PMID: 19434538 |
Ref: Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells. PMID: 20023572 Ref: Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. PMID: 20220543 |
Ref: Establishment and characterization of chronic-hypoxia-resistant gastric cancer cell line MNK45/HYP. PMID: 21336723 |
Ref: Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. PMID: 22929309 |
Ref: Preclinical evaluation of a novel c-Met inhibitor in a gastric cancer xenograft model using small animal PET. PMID: 22864665 Ref: Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target. PMID: 23135628 Ref: [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer. PMID: 23718763 Ref: Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer. PMID: 23935399 Ref: Factors affecting 18F-FDG uptake by metastatic lymph nodes in gastric cancer. PMID: 24045262 |
Ref: Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype. PMID: 24597478 Ref: Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha. PMID: 24982335 Ref: Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells. PMID: 25320508 |
Ref: Inhibition of glucose-transporter 1 (GLUT-1) expression reversed Warburg effect in gastric cancer cell MKN45. PMID: 25932183 Ref: Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer. PMID: 26193257 Ref: Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models. PMID: 26260219 Ref: The Apoptotic Effect of HIF-1alpha Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions. PMID: 26339797 Ref: Clinicopathological Parameters Influence Assessment of FDG SPECT in Gastric Cancer. PMID: 26897969 |
Ref: Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival. PMID: 26643879 Ref: Characterization of a near-infrared fluorescent DCPO-tagged glucose analogue for cancer cell imaging. PMID: 28012418 Ref: Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer. PMID: 28069585 Ref: Predictive value of glucose transporter-1 and glucose transporter-3 for survival of cancer patients: A meta-analysis. PMID: 28086215 Ref: Helicobacter pylori Induced Phosphatidylinositol-3-OH Kinase/mTOR Activation Increases Hypoxia Inducible Factor-1alpha to Promote Loss of Cyclin D1 and G0/G1 Cell Cycle Arrest in Human Gastric Cells. PMID: 28401064 Ref: miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1. PMID: 28440026 |
Ref: Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation. PMID: 29507622 Ref: [Value of immunocytochemistry in differential diagnosis of gastric adenocarcinoma, reactive mesothelial cells and malignant epithelial mesothelioma in metastatic effusion fluid]. PMID: 29534357 Ref: PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma. PMID: 30172011 |